Synergius Lab - Company finances
|
EUR
|
2023
From: 2023-02-09
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 40 | 13,724 | 122,877 |
| Profit before tax | 0 | 94 | 9,357 |
| Net profit | 0 | 80 | 8,796 |
| Equity | 1 | 94 | 10,555 |
| Liabilities | 0 | 0 | 0 |
| Non-current assets | 0 | 0 | 1,198 |
| Current assets | 1 | 94 | 9,357 |
| Total assets | 1 | 94 | 10,555 |
|
Taxes paid
|
|||
| STI taxes | - | 24 | 4,084 |
| Social insurance contributions | - | - | 3,753 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +34210.0% | +795.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 85.1% | 83.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 85.1% | 83.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.0% | 0.6% | 7.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.0% | 0.7% | 7.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 40 | 13,724 | 35,108 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Synergius Lab - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-10-03 | 2026-10-05 | 80.48 |
| 2026-07-01 | 2026-07-31 | 160.96 |
| 2026-05-03 | 2026-05-31 | 160.96 |
| 2026-01-21 | 2026-01-31 | 5.19 |
| 2025-12-17 | 2025-12-31 | 245.10 |
| 2025-11-18 | 2025-11-23 | 1505.42 |
| 2025-09-16 | 2025-09-16 | 865.37 |
| 2025-05-04 | 2025-05-31 | 72.45 |
| 2025-03-01 | 2025-03-31 | 72.45 |
| 2025-01-02 | 2025-01-31 | 64.50 |
| 2024-11-04 | 2024-11-30 | 129.00 |
| 2024-10-01 | 2024-11-03 | 64.50 |
| 2024-09-09 | 2024-09-30 | 63.78 |
| 2024-09-03 | 2024-09-08 | 165.56 |
| 2024-08-30 | 2024-09-02 | 101.06 |
| 2024-08-28 | 2024-08-29 | 124.28 |
| 2024-08-01 | 2024-08-27 | 129.13 |
| 2024-07-29 | 2024-07-31 | 64.63 |
| 2024-07-26 | 2024-07-28 | 64.50 |
| 2024-07-24 | 2024-07-25 | 64.63 |
| 2024-07-18 | 2024-07-23 | 64.50 |
| 2024-07-02 | 2024-07-17 | 69.49 |
| 2024-04-23 | 2024-07-01 | 4.99 |
| 2024-02-21 | 2024-04-22 | 4.85 |
| 2024-01-23 | 2024-02-20 | 4.89 |
| 2024-01-18 | 2024-01-22 | 4.85 |
| 2023-12-20 | 2023-12-21 | 19.42 |
Synergius Lab - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-12-18 | 2025-12-18 | 888.08 |
| 2025-11-20 | 2025-11-27 | 7.82 |
| 2025-11-18 | 2025-11-19 | 888.08 |
| 2025-10-21 | 2025-10-24 | 7.35 |
| 2025-10-18 | 2025-10-20 | 811.05 |
| 2025-09-19 | 2025-10-17 | 4.65 |
| 2025-05-13 | 2025-05-19 | 4.0 |
| 2024-08-16 | 2024-11-18 | 8.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Synergius Lab, MB (code 306244142) is a Small partnership engaged in business and other management consultancy activities. The company showed a very strong expansion in the latest financial year, 2025, when revenue reached €122.9K, up from €13.7K in 2024. Net profit increased to €8.8K in 2025 from €80 in 2024, while profit margin improved from 0.6% to 7.2%. Over the longer term, the business moved from only €40 of revenue in 2023 to €122.9K in 2025, indicating rapid scaling from a very small base. In 2025, total assets and equity were both €10.6K, and long-term assets amounted to €1.2K versus €9.4K of short-term assets, showing a balance sheet concentrated in current assets. The latest ratios point to high operating efficiency, with ROE and ROA both at 83.3%, equity ratio at 100.0%, and asset turnover at 11.64x. Revenue per employee was €41.0K and profit per employee €2.9K in 2025.